CT Abdomen and Pelvis With IV Contrast There is limited evidence to support the use of CT abdomen and pelvis with IV contrast for active surveillance of patients with clinically established low-risk prostate cancer. CT Abdomen and Pelvis Without and With IV Contrast There is limited evidence to support the use of CT abdomen and pelvis without and with IV contrast for active surveillance of patients with clinically established low-risk prostate cancer. CT Abdomen and Pelvis Without IV contrast There is limited evidence to support the use of CT abdomen and pelvis without IV contrast for active surveillance of patients with clinically established low-risk prostate cancer. CT Chest, Abdomen, and Pelvis With IV Contrast There is limited evidence to support the use of CT chest, abdomen, and pelvis with IV contrast for active surveillance of patients with clinically established low-risk prostate cancer. CT Chest, Abdomen, and Pelvis Without and With IV Contrast There is limited evidence to support the use of CT chest, abdomen, and pelvis without and with IV contrast for active surveillance of patients with clinically established low-risk prostate cancer. CT Chest, Abdomen, and Pelvis Without IV Contrast There is limited evidence to support the use of CT chest, abdomen, and pelvis without IV contrast for active surveillance of patients with clinically established low-risk prostate cancer. FDG-PET/CT Whole Body Because prostate cancer and metastases from it are generally not FDG-avid unlike most other malignancies, FDG- PET/CT may not be beneficial as part of active surveillance. FDG-PET/MRI Skull Base to Mid-Thigh Because prostate cancer and metastases from it are generally not FDG-avid unlike most other malignancies, FDG- PET/MRI may not be beneficial as part of active surveillance.
Pretreatment Detection Surveillance and Staging of Prostate Cancer. CT Abdomen and Pelvis With IV Contrast There is limited evidence to support the use of CT abdomen and pelvis with IV contrast for active surveillance of patients with clinically established low-risk prostate cancer. CT Abdomen and Pelvis Without and With IV Contrast There is limited evidence to support the use of CT abdomen and pelvis without and with IV contrast for active surveillance of patients with clinically established low-risk prostate cancer. CT Abdomen and Pelvis Without IV contrast There is limited evidence to support the use of CT abdomen and pelvis without IV contrast for active surveillance of patients with clinically established low-risk prostate cancer. CT Chest, Abdomen, and Pelvis With IV Contrast There is limited evidence to support the use of CT chest, abdomen, and pelvis with IV contrast for active surveillance of patients with clinically established low-risk prostate cancer. CT Chest, Abdomen, and Pelvis Without and With IV Contrast There is limited evidence to support the use of CT chest, abdomen, and pelvis without and with IV contrast for active surveillance of patients with clinically established low-risk prostate cancer. CT Chest, Abdomen, and Pelvis Without IV Contrast There is limited evidence to support the use of CT chest, abdomen, and pelvis without IV contrast for active surveillance of patients with clinically established low-risk prostate cancer. FDG-PET/CT Whole Body Because prostate cancer and metastases from it are generally not FDG-avid unlike most other malignancies, FDG- PET/CT may not be beneficial as part of active surveillance. FDG-PET/MRI Skull Base to Mid-Thigh Because prostate cancer and metastases from it are generally not FDG-avid unlike most other malignancies, FDG- PET/MRI may not be beneficial as part of active surveillance.